EW EBITDA Margin
Edwards Lifesciences · EBITDA Margin
EW EBITDA Margin
Latest reported24.30%period ending
EW TTM EBITDA Margin (19.24% → 24.30%)
TTM ebitda margin
High-resolution chart · PNG
EW ebitda margin history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Margin |
|---|---|
| 24.3048% | |
| 22.5399% | |
| 22.9316% | |
| 29.6067% | |
| 31.3662% | |
| 32.6641% | |
| 32.0455% | |
| 31.2671% | |
| 31.849% | |
| 30.1702% | |
| 29.8847% | |
| 31.1252% | |
| 31.0269% | |
| 34.0151% | |
| 35.4693% | |
| 34.0225% | |
| 33.7834% | |
| 35.3363% | |
| 35.2451% | |
| 35.7915% | |
| 36.2869% | |
| 23.6847% | |
| 23.3842% | |
| 22.327% | |
| 21.0445% | |
| 30.1604% | |
| 29.1536% | |
| 22.7936% | |
| 22.4888% | |
| 22.5805% | |
| 22.5932% | |
| 32.0866% | |
| 31.7994% | |
| 31.4513% | |
| 32.5619% | |
| 30.2851% | |
| 30.1541% | |
| 30.0867% | |
| 28.6432% | |
| 28.2934% | |
| 28.5105% | |
| 28.7115% | |
| 28.4597% | |
| 28.1939% | |
| 27.186% | |
| 26.4807% | |
| 24.1681% | |
| 23.1157% | |
| 23.1553% | |
| 24.0827% | |
| 25.2603% | |
| 26.2277% | |
| 26.1623% | |
| 24.7741% | |
| 23.805% | |
| 21.8765% | |
| 20.2791% | |
| 19.9042% | |
| 20.535% | |
| 21.1117% | |
| 22.4604% | |
| 22.9451% | |
| 22.5916% | |
| 22.6932% | |
| 25.2667% | |
| 25.6304% | |
| 27.6828% | |
| 25.7864% | |
| 22.0867% | |
| 21.4126% | |
| 17.686% | |
| 19.2875% | |
| 19.3417% | |
| 19.6476% | |
| 20.9422% | |
| 21.35% | |
| 21.9587% | |
| 21.9839% | |
| 24.2746% | |
| 25.0343% | |
| 25.2045% | |
| 25.4623% | |
| 23.2588% | |
| 22.8255% | |
| 22.8436% | |
| 22.7157% | |
| 20.9018% | |
| 20.7948% | |
| 20.4712% | |
| 19.5923% | |
| 20.9994% | |
| 20.4884% | |
| 12.1872% | |
| 12.6889% | |
| 13.1392% | |
| 13.635% | |
| 24.1599% | |
| 11.8207% | |
| 11.7052% | |
| 13.6254% |